These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35130355)

  • 1. Definition of drug-resistant epilepsy: A reappraisal based on epilepsy types.
    Asadi-Pooya AA; Farazdaghi M
    Acta Neurol Scand; 2022 May; 145(5):627-632. PubMed ID: 35130355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment response in newly diagnosed epilepsy: a syndromic approach.
    Asadi-Pooya AA; Farazdaghi M
    Neurol Res; 2022 Jul; 44(7):630-635. PubMed ID: 35037598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational therapy with lamotrigine or levetiracetam: Which one to select?
    Asadi-Pooya AA; Farazdaghi M
    J Clin Neurosci; 2022 May; 99():49-52. PubMed ID: 35240475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: A retrospective cohort study using the database of health insurance claims between 2015 and 2019.
    Jin K; Obara T; Hirano K; Hirai D; Kiuchi M; Tanaka T; Nakasato N
    Epilepsy Behav; 2022 Sep; 134():108841. PubMed ID: 35901657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of refractory idiopathic epilepsies.
    Perucca E
    Epilepsia; 2001; 42 Suppl 3():31-5. PubMed ID: 11520320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcome of idiopathic generalized epilepsy in adults.
    Gesche J; Christensen J; Hjalgrim H; Rubboli G; Beier CP
    Eur J Neurol; 2020 Apr; 27(4):676-684. PubMed ID: 31838768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tonic-clonic seizures in idiopathic generalized epilepsies: Prevalence, risk factors, and outcome.
    Asadi-Pooya AA; Homayoun M
    Acta Neurol Scand; 2020 Jun; 141(6):445-449. PubMed ID: 32030724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M; Al-Bachari S; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001415. PubMed ID: 33434292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
    Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Chiesa V; Dainese F; De Maria G; Didato G; Falcicchio G; Fanella M; Ferlazzo E; Fisco G; Gangitano M; Giallonardo AT; Giorgi FS; La Neve A; Mecarelli O; Montalenti E; Piazza F; Pulitano P; Quarato PP; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    CNS Drugs; 2021 Dec; 35(12):1289-1301. PubMed ID: 34476770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized onset seizures with focal evolution (GOFE) - A unique seizure type in the setting of generalized epilepsy.
    Linane A; Lagrange AH; Fu C; Abou-Khalil B
    Epilepsy Behav; 2016 Jan; 54():20-9. PubMed ID: 26619379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE).
    Mostacci B; Ranzato F; Giuliano L; La Neve A; Aguglia U; Bilo L; Durante V; Ermio C; Monti G; Zambrelli E; Lodi MAM; Galimberti CA
    Seizure; 2021 Feb; 85():26-38. PubMed ID: 33418162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies.
    Gesche J; Khanevski M; Solberg C; Beier CP
    Epilepsia; 2017 Apr; 58(4):e64-e69. PubMed ID: 28230254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of epileptiform activity, efficacy and tolerability of valproic acid in adults and adolescents with newly-diagnosed epilepsy].
    Karlov VA; Kozhokaru AB; Vlasov PN; Pushkar TN; Orlova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7):35-43. PubMed ID: 32790974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance in idiopathic generalized epilepsies: Evidence and concepts.
    Gesche J; Beier CP
    Epilepsia; 2022 Dec; 63(12):3007-3019. PubMed ID: 36102351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic generalized and focal epilepsy prevalence in the North American SUDEP Registry.
    Verducci C; Friedman D; Donner E; Devinsky O
    Neurology; 2020 Apr; 94(16):e1757-e1763. PubMed ID: 32217773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in patients with refractory idiopathic generalized epilepsy.
    Gomez-Ibañez A; McLachlan RS; Mirsattari SM; Diosy DC; Burneo JG
    Epilepsy Res; 2017 Feb; 130():69-73. PubMed ID: 28157601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy].
    Szwed-Białozyt B; Marszał E
    Przegl Lek; 2003; 60 Suppl 1():5-9. PubMed ID: 12945154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study.
    Rosati A; Boncristiano A; Doccini V; Pugi A; Pisano T; Lenge M; De Masi S; Guerrini R
    Epilepsia; 2019 Nov; 60(11):2255-2262. PubMed ID: 31630399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic epilepsies imitating idiopathic generalized epilepsies.
    Oguni H
    Epilepsia; 2005; 46 Suppl 9():84-90. PubMed ID: 16302880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of sleep macrostructure parameters and idiopathic epilepsies.
    Barreto JR; Fernandes RM; Sakamoto AC
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):353-7. PubMed ID: 12131930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.